| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |